Standout Papers

A New Equation to Estimate Glomerular Filtration Rate 2003 2026 2010 2018 18.9k
  1. A New Equation to Estimate Glomerular Filtration Rate (2009)
    Andrew S. Levey, Lesley A. Stevens et al. Annals of Internal Medicine
  2. Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate (2006)
    Andrew S. Levey, Josef Coresh et al. Annals of Internal Medicine
  3. Prevalence of Chronic Kidney Disease in the United States (2007)
    Josef Coresh, Elizabeth Selvin et al. JAMA
  4. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification (2003)
    Andrew S. Levey, Josef Coresh et al. Annals of Internal Medicine
  5. Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C (2012)
    Lesley A. Inker, Christopher H. Schmid et al. New England Journal of Medicine
  6. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis (2010)
    Kunihiro Matsushita, Marije van der Velde et al. The Lancet
  7. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease (2003)
    Mark J. Sarnak, Andrew S. Levey et al. Circulation
  8. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) (2005)
    Andrew S. Levey, Kai‐Uwe Eckardt et al. Kidney International
  9. Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate (2006)
    Lesley A. Stevens, Josef Coresh et al. New England Journal of Medicine
  10. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third national health and nutrition examination survey (2002)
    Josef Coresh, Brad C. Astor et al. American Journal of Kidney Diseases
  11. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report (2010)
    Andrew S. Levey, Paul E. de Jong et al. Kidney International
  12. Expressing the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate with Standardized Serum Creatinine Values (2007)
    Andrew S. Levey, Josef Coresh et al. Clinical Chemistry
  13. Chronic kidney disease (2011)
    Andrew S. Levey, Josef Coresh The Lancet
  14. Glycated Hemoglobin, Diabetes, and Cardiovascular Risk in Nondiabetic Adults (2010)
    Elizabeth Selvin, Michael W. Steffes et al. New England Journal of Medicine
  15. Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes (2007)
    Andrew S. Levey, R. C. Atkins et al. Kidney International
  16. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis (2012)
    Caroline S. Fox, Kunihiro Matsushita et al. The Lancet
  17. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease (2003)
    Mark J. Sarnak, Andrew S. Levey et al. Hypertension
  18. Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD (2008)
    Lesley A. Stevens, Josef Coresh et al. American Journal of Kidney Diseases
  19. Evolving importance of kidney disease: from subspecialty to global health burden (2013)
    Kai‐Uwe Eckardt, Josef Coresh et al. The Lancet
  20. Comparison of Risk Prediction Using the CKD-EPI Equation and the MDRD Study Equation for Estimated Glomerular Filtration Rate (2012)
    Kunihiro Matsushita, Bakhtawar K. Mahmoodi et al. JAMA
  21. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts (2011)
    Marije van der Velde, Kunihiro Matsushita et al. Kidney International
  22. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community (2002)
    Guruprasad Manjunath, Hocine Tighiouart et al. Journal of the American College of Cardiology
  23. Cystatin C versus Creatinine in Determining Risk Based on Kidney Function (2013)
    Michael G. Shlipak, Kunihiro Matsushita et al. New England Journal of Medicine
  24. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts (2011)
    Ron T. Gansevoort, Kunihiro Matsushita et al. Kidney International
  25. Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000 (2004)
    Josef Coresh, Danita D. Byrd-Holt et al. Journal of the American Society of Nephrology
  26. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate (2002)
    Josef Coresh, Brad C. Astor et al. American Journal of Kidney Diseases
  27. Association Between Cholesterol Level and Mortality in Dialysis Patients (2004)
    Yongmei Liu, Josef Coresh et al. JAMA
  28. Factors other than glomerular filtration rate affect serum cystatin C levels (2009)
    Lesley A. Stevens, Christopher H. Schmid et al. Kidney International
  29. Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities Study (2011)
    Justin T. Saunders, Vijay Nambi et al. Circulation
  30. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study (2008)
    Abbas Dehghan, Anna Köttgen et al. The Lancet
  31. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts (2011)
    Brad C. Astor, Kunihiro Matsushita et al. Kidney International
  32. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). (2002)
    Brad C. Astor, Paul Muntner et al. PubMed
  33. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout (2009)
    Owen M. Woodward, Anna Köttgen et al. Proceedings of the National Academy of Sciences
  34. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease (2016)
    Benjamin Lazarus, Chen Yuan et al. JAMA Internal Medicine
  35. Comparative Performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study Equations for Estimating GFR Levels Above 60 mL/min/1.73 m2 (2010)
    Lesley A. Stevens, Christopher H. Schmid et al. American Journal of Kidney Diseases
  36. Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition (2017)
    Rebecca F. Gottesman, Andrea L.C. Schneider et al. JAMA
  37. GFR Estimation: From Physiology to Public Health (2014)
    Andrew S. Levey, Lesley A. Inker et al. American Journal of Kidney Diseases
  38. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort (2017)
    Rebecca F. Gottesman, Marilyn S. Albert et al. JAMA Neurology
  39. GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration (2014)
    Andrew S. Levey, Lesley A. Inker et al. American Journal of Kidney Diseases
  40. Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018 (2021)
    Michael Fang, Dan Wang et al. New England Journal of Medicine
  41. Stroke Incidence and Mortality Trends in US Communities, 1987 to 2011 (2014)
    Silvia Koton, Andrea L.C. Schneider et al. JAMA
  42. Midlife Hypertension and 20-Year Cognitive Change (2014)
    Rebecca F. Gottesman, Andrea L.C. Schneider et al. JAMA Neurology
  43. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency (2019)
    Andrew S. Levey, Ron T. Gansevoort et al. American Journal of Kidney Diseases
  44. Plant‐Based Diets Are Associated With a Lower Risk of Incident Cardiovascular Disease, Cardiovascular Disease Mortality, and All‐Cause Mortality in a General Population of Middle‐Aged Adults (2019)
    Hyunju Kim, Laura E. Caulfield et al. Journal of the American Heart Association
  45. Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate (2015)
    Morgan E. Grams, Yingying Sang et al. New England Journal of Medicine
  46. The ARIC (Atherosclerosis Risk In Communities) Study (2021)
    Jacqueline D. Wright, Aaron R. Folsom et al. Journal of the American College of Cardiology
  47. Association of Midlife to Late-Life Blood Pressure Patterns With Incident Dementia (2019)
    Keenan A. Walker, A. Richey Sharrett et al. JAMA
  48. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association (2023)
    Sadiya S. Khan, Josef Coresh et al. Circulation
  49. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies (2022)
    Jingning Zhang, Diptavo Dutta et al. Nature Genetics
  50. Cardiovascular Disease Risk Among Cancer Survivors (2022)
    Roberta Florido, Natalie Daya et al. Journal of the American College of Cardiology
  51. Lifetime risk and projected burden of dementia (2025)
    Michael Fang, Jordan Weiss et al. Nature Medicine

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 75 standout
Sub-graph 1 of 23

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
2023 StandoutScience
3 intermediate papers

Works of Josef Coresh being referenced

Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort
2017 Standout
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
2005
and 8 more

Author Peers

Author Last Decade Papers Cites
Josef Coresh 49539 29995 16406 936 112.1k
Andrew S. Levey 64184 30240 13235 503 121.9k
Tom Greene 38211 17550 11025 475 79.0k
Giuseppe Remuzzi 36624 17583 11366 1.3k 92.7k
Glenn M. Chertow 41469 11265 7416 800 67.2k
Rinaldo Bellomo 37319 12341 5057 1.6k 96.4k
John W. Kusek 27040 12694 6522 366 58.5k
George L. Bakris 11719 34537 24604 836 66.0k
Jean‐Louis Vincent 14426 16697 5085 1.4k 136.1k
Daniel Levy 6799 88384 18947 807 138.9k
Mark Woodward 7959 18496 14717 983 63.2k

All Works

Loading papers...

Rankless by CCL
2026